Клиническое значение инсулинорезистентности у недиабетических пациентов с ранними формами неалкогольной жировой болезни печени
- Авторы: Шиповская А.А.1, Дуданова О.П.1, Курбатова И.В.2
-
Учреждения:
- ФГБОУ ВО «Петрозаводский государственный университет» Медицинский институт
- Институт биологии - обособленное подразделение ФГБУН Федерального исследовательского центра «Карельский научный центр Российской академии наук»
- Выпуск: Том 90, № 8 (2018)
- Страницы: 63-68
- Раздел: Передовая статья
- URL: https://journals.rcsi.science/0040-3660/article/view/32791
- DOI: https://doi.org/10.26442/terarkh201890863-68
- ID: 32791
Цитировать
Полный текст
Аннотация
Полный текст
Открыть статью на сайте журналаОб авторах
Анастасия Андреевна Шиповская
ФГБОУ ВО «Петрозаводский государственный университет» Медицинский институтаспирант каф. пропедевтики внутренних болезней и гигиены Медицинского института ПетрГУ Петрозаводск, Россия
Ольга Петровна Дуданова
ФГБОУ ВО «Петрозаводский государственный университет» Медицинский институт
Email: odudanova@gmail.com
д.м.н., проф., зав. каф. пропедевтики внутренних болезней и гигиены Медицинского института ПетрГУ Петрозаводск, Россия
Ирина Валерьевна Курбатова
Институт биологии - обособленное подразделение ФГБУН Федерального исследовательского центра «Карельский научный центр Российской академии наук»к.б.н., н.с. лаб. генетики ИБ КарНЦ РАН Петрозаводск, Россия
Список литературы
- Ивашкин В.Т., Драпкина О.М., Маев И.В., Трухманов А.С., Блинов Д.В., Пальгова Л.К., Цуканов В.В., Ушакова Т.И. Распространенность неалкогольной жировой болезни печени у пациентов амбулаторно - поликлинической практики в Российской Федерации: результаты исследования DIREG 2. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;(6):31-41.
- Benedict M, Zhang X. Non - alcoholic fatty liver disease: An expanded review. World J Hepatol. 2017;9(16):715-732. doi: 10.4254/wjh. v9.i16.715
- Byrne C.D, Targher G. Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease: Implications for Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2014;34(6):1155-1161. doi: 10.1161/atvbaha.114.303034
- Boutens L, Stienstra R. Adipose tissue macrophages: going off track during obesity. Diabetologia. 2016;59:879-884. doi: 10.1007/s00125-016-3904-9
- Lonardo A, Nascimbeni F, Maurantonio M, Marrazzo A, Rinaldi L, Adinolfi L. Nonalcoholic fatty liver disease: Evolving paradigms. E World J Gastroenterol. 2017;23(36):6571-6592. doi: 10.3748/wjg. v23. i36.6571
- Petta S, Gastaldelli A, Rebelos E, Bugianesi E, Messa P, Miele L, Svegliati-Baroni G, Valenti L, Bonino F. Pathophysiology of Non Alcoholic Fatty Liver Disease. Int J Mol Sci. 2016;17(12):pii: E2082.
- Pasarín M, Abraldes J.G, Liguori E, Kok B, La Mura V. Intrahepatic vascular changes in non - alcoholic fatty liver disease: potential role of insulin - resistance and endothelial dysfunction. World J Gastroenterol. 2017;23(37):6777-6787. doi: 10.3748/wjg.v23.i37.6777
- Ройтберг Г.Е., Шархун О.О. Особенности прогрессирования поражения печени при инсулинорезистентности. Медицина. 2017;5:99-107.
- Jung K.Y, Cho S.Y, Kim H.J, Kim S.B, Song I.H. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology. J Clin Gastroenterol. 2014;48(10):883-888. doi: 10.1097/mcg.0000000000000065
- Ballestri S, Nascimbeni F, Romagnoli D, Lonardo A. The independent predictors of non - alcoholic steatohepatitis and its individual histological features: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Hepatol Res. 2016;46:1074-1087. doi: 10.1111/hepr.12656
- Park B.H, Yoon J.M, Kim J.H, Moon J.H, Lee Y.H, Jang S.M, Kim Y.J. Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis. Yonsei Med J. 2017;58(4):756-762. doi: 10.3349/ymj.2017.58.4.756
- Cruz M.A, Cruz J.F, Macena L.B, de Santana D.S, Oliveira C.C, Lima S.O, Franca A.V. Association of the Nonalcoholic Hepatic Steatosis and Its Degrees With the Values of Liver Enzymes and Homeostasis Model Assessment-Insulin Resistance Index. Gastroenterol Res. 2015 Oct;8(5):260-264. doi: 10.14740/gr685w
- Arata M, Nakajima J, Nishimata S, Nagata T, Kawashima H. Nonalcoholic steatohepatitis and insulin resistance in children. World J Diabetes. 2014;5(6):917-23. doi: 10.4239/wjd.v5.i6.917
- Maximos M, Bril F, Portillo Sanchez P, Lomonaco R, Orsak B, Biernacki D, Suman A, Weber M, Cusi K. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease. Hepatology. 2015;61(1):153-60. doi: 10.1002/hep.27395
- Kitade M, Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Shirai Y, Yamazaki M, Uemura M, Yamao J, Fujimoto M, Mitoro A, Toyohara M, Sawai M, Yoshida M, Morioka C, Tsujimoto T, Kawaratani H, Fukui H. Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non - alcoholic steatohepatitis. World J Gastroenterol. 2009;15(41):5193-5199. doi: 10.3748/wjg.15.5193
- Polyzos S.A, Kountouras J, Papatheodorou A, Katsiki E, Patsiaoura K, Zafeiriadou E, Papadopoulou E, Zavos C, Terpos E. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index. Ann Hepatol. 2013;12(5):749-757.
- Angulo P, Hui J.M, Marchesini G, Bugianesi E, George J, Farrell G.C, Enders F, Saksena S, Burt A.D, Bida J.P, Lindor K, Sanderson S.O, Lenzi M, Adams L.A, Kench J, Therneay T.M, Day C.P. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846-854. doi: 10.1002/ hep.21496
- Wannamethee S.G, Shaper A.G, Lennon L, Whincup P.H. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care. 2005 Dec;28(12):2913-2918. doi: 10.2337/diacare.28.12.2913
- Sattar N, Scherbakova O, Ford I, O’Reilly D.S, Stanley A, Forrest E, Macfarlane P.W, Packard C.J, Cobbe S.M, Shepherd J. The West of Scotland Coronary Prevention Study: Elevated alanine aminotransferase predicts new - onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes. 2004;53(11):2855-60. doi: 10.2337/diabetes.53.11.2855
- Del Ben M, Polimeni L, Baratta F, Bartimoccia S, Carnevale R, Loffredo L, Pignatelli P, Violi F, Angelico F. Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver. Int J Hepatol. 2014;2014:784985. doi: 10.1155/ 2014/784985
- Hossain I.A, Rahman Shah M.M, Rahman M.K, Ali L. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD. Diabetes Metab Syndr. 2016;10(1 Suppl 1):S25-S29. doi: 10.1016/j.dsx.2015.09.005
- Mankowska-Cyl A, Krintus M, Rajewski P, Sypniewska G. Gamma - glutamyltransferase activity as a surrogate biomarker of metabolic health status in young nondiabetic obese women. Biomark Med. 2017;11(5):449-457. doi: 10.2217/bmm-2016-0332
- Kunutsor S.K, Apekey T.A, Seddoh D. Gamma glutamyltransferase and metabolic syndrome risk: a systematic review and dose - response meta - analysis. Int J Clin Pract. 2015;69(1):136-344. doi: 10.1111/ ijcp.12507
- Schreuder T.C, Marsman H.A, Lenicek M, van Werven J.R, Nederveen A.J, Jansen P.L, Schaap F.G. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol. 2010;298(3):G440-G445. doi: 10.1152/ajpgi.00322.2009
- Chen Z, Yu R, Xiong Y, Du F, Zhu S. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):203. doi: 10.1186/s12944-017-0572-9
- Bril F, Sninsky J.J, Baca A.M, Superko H.R, Portillo Sanchez P, Biernacki D, Maximos M, Lomonaco R, Orsak B, Suman A, Weber M.H, Mc Phaul M.J, Cusi K. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD. J Clin Endocrinol Metab. 2016;101(2):644-52. doi: 10.1210/jc.2015-3111
- Siddiqui M.S, Fuchs M, Idowu M.O, Luketic V.A, Boyett S, Sargeant C, Stravitz R.T, Puri P, Matherly S, Sterling R.K, Contos M, Sanyal A.J. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. Clin Gastroenterol Hepatol. 2015;13(5):1000-1008.e3. doi: 10.1016/j.cgh.2014.10.008
- Younossi Z.M, Loomba R, Anstee Q.M, Rinella M.E, Bugianesi E, Marchesini G, Neuschwander-Tetri B.A, Serfaty L, Negro F, Caldwell S.H, Ratziu V, Corey K.E, Friedman S.L, Abdelmalek M.F, Harrison S.A, Sanyal A.J, Lavine J.E, Mathurin P, Charlton M.R, Goodman Z.D, Chalasani N.P, Kowdley K.V, George J, Lindor K. Diagnostic Modalities for Non - alcoholic Fatty Liver Disease (NAFLD), Non - alcoholic Steatohepatitis (NASH) and Associated Fibrosis. Hepatology. 2017 Dec 9 [Epub ahead of print].
- Gentili A, Daviddi G, De Vuono S, Ricci M.A, Di Filippo F, Alaeddin A, Mannarino M.R, Boni M, Vaudo G, Lupattelli G. Non - alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients. Dig Liver Dis. 2016 Aug;48(8):904-908. doi: 10.1016/j.dld.2016.04.004
Дополнительные файлы
